Evidence map›Paper›PMID 36815863›Full record

ArticleBehavioural neurology2023

Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.

P M Luna, J F López-Paz, M García, I Amayra, O Martínez, M Pérez, A A Rodríguez, P Pérez-Núñez, I Ceberio, N Mansilla and 1 more

Open access · goldAbstract read
In one paragraph

Article in Behavioural neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Phenylketonuria as an Adherence Disease.Patient preference and adherence · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

P M LunaUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.ORCID https://orcid.org/0000-0002-7590-2127
J F López-PazUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
M GarcíaUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
I AmayraUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
O MartínezUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
M PérezUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
A A RodríguezUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
P Pérez-NúñezUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
I CeberioUniversity of Deusto, Department of Psychology, Av. de las Universidades 24, Bilbao 48007, Spain.
N MansillaSuportias, Nursing Department, Av. Juan Carlos I, 13, Madrid 28806, Spain.
C SoriaSuportias, Health Psychology Department, Av. Juan Carlos I, 13, Madrid 28806, Spain.
Universidad de Deusto · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The early introduction of a low phenylalanine (Phe) diet has been demonstrated to be the most successful treatment in subjects with phenylketonuria (PKU), especially for preventing severe cognitive and neurological damages. However, it still concerns that even if treated in the first months of life with supplements and following a diet, they can show slight scores below people without PKU in neuropsychological assignments. We investigated 20 adults with classical PKU aged 19-48 years (mean age 29 years) and 20 heathy controls matched by age, gender, and years of education. Patients and controls were assessed with an extended neuropsychological battery, as well as psychological aspects and quality of life, also the last Phe level result was obtained. Results showed that the most affected cognitive domains are processing speed, executive functioning, memory, and also theory of mind, but very well-preserved verbal fluency, language, and visuospatial functioning. In quality of life, some significant results were seen specially in anxiety of Phe levels, anxiety of Phe levels during pregnancy, guilt if poor adherence to supplements, and if dietary protein restriction not followed. No significant results were obtained for the psychological variables. In conclusion, it has been shown that a combination of a low Phe diet, supplement intake, and keeping Phe levels in a low range seems appropriate to have the most normal and alike cognitive performance to persons without PKU.

Indexed as

PhenylketonuriasQuality of LifeAdultCognitionExecutive FunctionHumansPhenylalaninePhenylalanine

Identifiers

PMID36815863
PMCPMC9931468
OpenAlexW4319458756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.